ES2159621T3 - Composiciones farmaceuticas que comprenden hirudina. - Google Patents

Composiciones farmaceuticas que comprenden hirudina.

Info

Publication number
ES2159621T3
ES2159621T3 ES95905223T ES95905223T ES2159621T3 ES 2159621 T3 ES2159621 T3 ES 2159621T3 ES 95905223 T ES95905223 T ES 95905223T ES 95905223 T ES95905223 T ES 95905223T ES 2159621 T3 ES2159621 T3 ES 2159621T3
Authority
ES
Spain
Prior art keywords
hirudine
pharmaceutical compositions
hirudin
sugar
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95905223T
Other languages
English (en)
Spanish (es)
Inventor
Tudor Arvinte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCP Gen Pharma AG
Novartis AG
Original Assignee
UCP Gen Pharma AG
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCP Gen Pharma AG, Novartis AG filed Critical UCP Gen Pharma AG
Application granted granted Critical
Publication of ES2159621T3 publication Critical patent/ES2159621T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES95905223T 1994-01-26 1995-01-25 Composiciones farmaceuticas que comprenden hirudina. Expired - Lifetime ES2159621T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9401447A GB9401447D0 (en) 1994-01-26 1994-01-26 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ES2159621T3 true ES2159621T3 (es) 2001-10-16

Family

ID=10749331

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95905223T Expired - Lifetime ES2159621T3 (es) 1994-01-26 1995-01-25 Composiciones farmaceuticas que comprenden hirudina.

Country Status (20)

Country Link
US (1) US6436901B1 (hu)
EP (1) EP0758905B1 (hu)
JP (2) JP3260760B2 (hu)
AT (1) ATE201996T1 (hu)
AU (1) AU1391595A (hu)
CA (1) CA2181907A1 (hu)
DE (1) DE69521315T2 (hu)
DK (1) DK0758905T3 (hu)
ES (1) ES2159621T3 (hu)
FI (1) FI962979A (hu)
GB (1) GB9401447D0 (hu)
GR (1) GR3036574T3 (hu)
HU (1) HU214823B (hu)
IL (1) IL112388A0 (hu)
MX (1) MX9603010A (hu)
NO (1) NO963113L (hu)
NZ (1) NZ278433A (hu)
PT (1) PT758905E (hu)
WO (1) WO1995020399A1 (hu)
ZA (1) ZA95577B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
DE19607239A1 (de) 1996-02-27 1997-08-28 Behringwerke Ag Pharmazeutische Zusammensetzung, enthaltend Hirudin und Verfahren zu deren Herstellung
US6653062B1 (en) 2000-07-26 2003-11-25 Wisconsin Alumni Research Foundation Preservation and storage medium for biological materials
WO2002064157A2 (en) * 2001-01-23 2002-08-22 Boston Scientific Corporation Localized myocardial injection method for treating ischemic myocardium
US7795205B2 (en) * 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
ES2290844T3 (es) 2004-10-29 2008-02-16 Pharma Mar S.A., Sociedad Unipersonal Composiciones que comprenden ecteinascidinas y un disacarido.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342139A1 (de) * 1983-11-22 1985-05-30 Ciba-Geigy Ag, Basel Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
CA1341417C (fr) 1984-03-27 2003-01-21 Paul Tolstoshev Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine
DE3438296A1 (de) 1984-04-18 1985-11-07 Hoechst Ag, 6230 Frankfurt Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel
DE3445532A1 (de) 1984-12-13 1986-06-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Hirudin-pa, desulfatohirudine-pa, verfahren zur herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
DE3804600A1 (de) 1988-02-13 1989-08-24 Basf Ag Mischung aus einer thrombolytisch wirkenden und einer antithrombotischen substanz
GB8817161D0 (en) * 1988-07-19 1988-08-24 Ciba Geigy Ag Modified proteins
IT1243358B (it) 1990-07-23 1994-06-10 Iketon Farmaceutici Srl Composizioni farmaceutiche per la somministrazione orale di irudina
AU659432B2 (en) 1991-03-08 1995-05-18 Novartis Ag A method for the inhibition or prevention of tumor cell metastasis with hirudin
GB9303275D0 (en) 1993-02-18 1993-04-07 Ciba Geigy Ag Pharmaceutical compositions
GB9401448D0 (en) 1994-01-26 1994-03-23 Ciba Geigy Ag Stable dry powders

Also Published As

Publication number Publication date
DK0758905T3 (da) 2001-09-03
WO1995020399A1 (en) 1995-08-03
ATE201996T1 (de) 2001-06-15
GR3036574T3 (en) 2001-12-31
CA2181907A1 (en) 1995-08-03
JPH09508377A (ja) 1997-08-26
EP0758905A1 (en) 1997-02-26
DE69521315T2 (de) 2001-10-31
EP0758905B1 (en) 2001-06-13
DE69521315D1 (de) 2001-07-19
NZ278433A (en) 1997-03-24
FI962979A0 (fi) 1996-07-26
JP2001026548A (ja) 2001-01-30
IL112388A0 (en) 1995-03-30
JP3260760B2 (ja) 2002-02-25
AU1391595A (en) 1995-08-15
US6436901B1 (en) 2002-08-20
FI962979A (fi) 1996-07-26
HU9602037D0 (en) 1996-09-30
NO963113D0 (no) 1996-07-25
HUT74879A (en) 1997-02-28
NO963113L (no) 1996-09-17
HU214823B (hu) 1998-06-29
GB9401447D0 (en) 1994-03-23
PT758905E (pt) 2001-11-30
MX9603010A (es) 1998-01-31
ZA95577B (en) 1995-07-26

Similar Documents

Publication Publication Date Title
NO964966L (no) Lactobacillusstammer av human opprinnelse, blandinger samt anvendelse derav
BR9710372B1 (pt) composto, e, composiÇço farmacÊutica.
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
ATE180776T1 (de) Naphthylverbindungen, zwischenprodukte, zusammensetzungen und methoden
TR200001218T2 (tr) İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler.
DE68913693D1 (de) Aerosol-Zusammensetzung.
PT1112266E (pt) 4-amino-2-aril-pirimidinas substituidas, sua preparacao, sua utilizacao e composicoes farmaceuticas que as contem.
BG103968A (en) Pharmaceutical antiviral composition containing glycirricinic acid and at least one protein with antiviral activity
ES2159621T3 (es) Composiciones farmaceuticas que comprenden hirudina.
ITRM940217A0 (it) Composizioni pesticide.
IT8522359A0 (it) Composizioni farmaceutiche che li derivati di vitamina d,contengono e loro precursori.
ATE28188T1 (de) Antikonvulsive mittel.
DK0977871T3 (da) Neurotrypsin
ITRM940378A0 (it) Composizioni erbicide.
TR27743A (tr) Sulu, akici fenazakin bilesimi.
DE68912215T2 (de) Aerosolzusammensetzung.
MX9102369A (es) 2,6-alcoxifenil-alquilcetonas y composicion herbicida que las contiene.
DK0804098T3 (da) Filter til tobaksrøg
MX9203103A (es) Androsta-1-,4-dien-3,17-dionas substituidas y composiciones farmaceuticas que las contienen.
EE9800323A (et) HIV proteaasi inhibiitorit VX 478 ja vees lahustuva vitamiin E derivaati vitamiin E-TPGSi sisaldavad preparaadid
FR2701395B1 (fr) Composition parfumante.
TR199500776A2 (tr) Farmasötik bilesimler.
BR1100782A (pt) Fenilimidazolidinas substituìdas, sua aplicação como medicamentos e as composições farmacêuticas que as contêm
ATE102641T1 (de) Aerosol-zusammensetzung.
ITFI930007A0 (it) Tiodiazepine, loro processidi preparazione e composizioni farmaceuti- che che le contengono.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 758905

Country of ref document: ES